about
Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles.Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.A microneedle patch containing measles vaccine is immunogenic in non-human primates.Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedlesAn economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.Energy Transfer Mechanisms during Molecular Delivery to Cells by Laser-Activated Carbon Nanoparticles.Role of cytoskeletal mechanics and cell membrane fluidity in the intracellular delivery of molecules mediated by laser-activated carbon nanoparticles.Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries.Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle InjectionThickness and Closure Kinetics of the Suprachoroidal Space Following Microneedle Injection of Liquid Formulations.Microneedle patches for vaccination in developing countries.A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.DNA uptake, intracellular trafficking and gene transfection after ultrasound exposure.Intracellular delivery of molecules using microfabricated nanoneedle arrays.Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch.The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque.Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.Photoporation Using Carbon Nanotubes for Intracellular Delivery of Molecules and Its Relationship to Photoacoustic Pressure.Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy.Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice.Electrical impedance spectroscopy for rapid and noninvasive analysis of skin electroporation.Human Suction Blister Fluid Composition Determined Using High-Resolution Metabolomics.Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.Rabies vaccination in dogs using a dissolving microneedle patch.Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy.Long-term stability of influenza vaccine in a dissolving microneedle patch.Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects.Targeted Drug Delivery Within the Eye Through the Suprachoroidal Space.A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.Inkjet printing of transdermal microneedles for the delivery of anticancer agents.Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice
P50
Q27335339-C1219D2F-5550-44DB-A6B7-1F779804A3B7Q33916017-DEFFFBB5-6928-46F9-AF6A-6EAB393416F2Q35731299-C51B4E0F-405A-4426-8C5B-5E2AF3A50FE2Q35811003-C6F8ABD8-ED4E-4557-A75D-2BF1820BB9F6Q36011315-386DCB99-2F6A-43DE-A4D4-CDA7E490DF52Q36157157-22D367DD-C95A-421D-88A1-30D090304429Q36215695-0E346314-53C9-4074-AFCD-7B02FEAEE335Q36327075-F7FEC813-E8E9-4C5B-9903-6444AF9F215AQ36408938-68BC85D9-55FF-423F-A72F-EB8FD2AEA224Q36649709-FEF42CAB-2C19-421A-8B13-EA9F5370534BQ36828342-C797317A-8EFF-4794-8C0B-B7698074E080Q37616184-363B79E9-B048-44CD-80A7-CD765AAF703FQ37616194-E695592C-0A84-4D02-8D0D-658D16EF2586Q38646712-D3222852-11D6-4912-BC3B-84CDAA8B2F50Q38667809-4AE4E5C0-C7F0-42AE-8BF0-BCBD57636B50Q38757890-95FF729D-875B-46CE-809D-3162671DB33AQ38771866-192EEFCD-8ED6-4FFB-9905-358BDBEF67ADQ38800673-96674CF8-2DBF-42F0-A851-1996132AD249Q39289999-A90EA777-3749-4C00-B5BF-1AF0BF129AE5Q40073524-48E94BD4-E777-4F94-9A21-5102BB43387BQ40151720-C180BDB1-4AE0-4C7A-B1BE-0F6F447D2045Q41447125-FF14173B-961D-4EF4-905E-4B6836029924Q42156511-E9929410-A975-4ECD-A2D7-8D56107F41B2Q47101549-DD4F9A50-C3ED-432E-A318-9AB0F8E468F7Q47283193-FAA8BAA0-1370-4472-9304-363ECFBA53E2Q47428301-683985B3-47BD-43B6-8051-A804766FFF17Q47554106-97E70A68-0500-417C-8F02-DD9B68041BB1Q47765014-0EC0CD16-56B3-439F-A7D8-64E1FE386B28Q50100305-CAE2155F-EA0A-4F1B-91CC-F337CD6ED446Q50533261-FD607829-B25F-4381-AEDD-CD28A89DC100Q50775009-9D60F2C5-C47C-4CAA-A0B5-6E4109A3B0BFQ50884744-C04CC0E3-39D5-4C6F-9EA2-F37A9995EA08Q50890208-236FAC91-5447-4A41-8A6C-21CE193027ABQ50931417-9C0F1FB3-6A45-41FA-A57D-7AEF06F41D77Q50962760-AD4B0565-0BAB-4A4D-8A58-F35C994B3E8EQ51099790-9C0DCE13-307A-429C-894B-24FCCF7676AEQ52559076-6A638FB7-6214-4904-8A9A-51D66FFB36D5Q52673868-B97FD66E-31F0-4B74-BE4A-BF529443CCAAQ53330393-49B8FB39-6871-473A-8007-5DFB6D360C58Q56221441-F2460F63-F26C-4BD5-ACC2-9EFB34F2E316
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
M R Prausnitz
@en
M R Prausnitz
@nl
type
label
M R Prausnitz
@en
M R Prausnitz
@nl
prefLabel
M R Prausnitz
@en
M R Prausnitz
@nl
P31
P496
0000-0002-9076-8448